Amygdalin (Vitamin B17) Effect on Glioblastoma: Focus on Oxidant Capacity and Antioxidant Status
Recent Trends in Pharmacology · 2024
DOI: 10.62425/rtpharma.1523732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Recent Trends in Pharmacology, 2024. Verfasst von Sıdıka Genç und 6 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objective
Amygdalin (Vitamin B-17) is a type of vitamin, naturally found in many fruits and plants. The aim of the study was the evaluation of Amygdalin effect on the oxidant capacity and oxidant status of the T98G cancer cells. A T98G cell line was used in the study. Cell viability and oxidative stress evaluation were done.
Methods
Amygdalin was used at 1, 4, and 8 µg/mL doses. TAC and TOS values were measured.
Results
According to the result, amygdalin 8 µg/mL shows the highest anticancer effects. TAC level was 3.2 Trolox Equiv/L and TOS was 3.6 H2O2 Equiv/L.
Conclusion
Vit B17 can increase oxidative stress in T98G cells and decrease cell viability
Zitieren
APA
Genç, S., Karabulut, K., Niğde, E., Aydin, Y. E., Aydın, B., Aydın, A. E., & Taghizadehghalehjoughi, A. (2024). Amygdalin (Vitamin B17) Effect on Glioblastoma: Focus on Oxidant Capacity and Antioxidant Status. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1523732
Vancouver
Genç S, Karabulut K, Niğde E, Aydin YE, Aydın B, Aydın AE, et al. Amygdalin (Vitamin B17) Effect on Glioblastoma: Focus on Oxidant Capacity and Antioxidant Status. Recent Trends in Pharmacology. 2024. doi:10.62425/rtpharma.1523732
BibTeX
@article{Gen2024,
author = {Genç, Sıdıka and Karabulut, Kübra and Niğde, Esmanur and Aydin, Yunus Emre and Aydın, Beyzanur and Aydın, Alperen Enes and Taghizadehghalehjoughi, Ali},
title = {Amygdalin (Vitamin B17) Effect on Glioblastoma: Focus on Oxidant Capacity and Antioxidant Status},
journal = {Recent Trends in Pharmacology},
year = {2024},
doi = {10.62425/rtpharma.1523732}
}
EUVIMED